1 Study Coverage 1.1 Infection Prevention Product Introduction 1.2 Market by Type 1.2.1 Global Infection Prevention Market Size Growth Rate by Type 1.4.2 Disinfectors 1.4.3 Sterilization Equipment 1.2.4 Others 1.3 Market by Application 1.3.1 Global Infection Prevention Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Infection Prevention Sales Estimates and Forecasts 2016-2027 2.2 Global Infection Prevention Revenue Estimates and Forecasts 2016-2027 2.3 Global Infection Prevention Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Infection Prevention Regions by Sales 2.4.1 Global Top Infection Prevention Regions by Sales (2016-2021) 2.4.2 Global Top Infection Prevention Regions by Sales (2022-2027) 2.5 Global Top Infection Prevention Regions by Revenue 2.5.1 Global Top Infection Prevention Regions by Revenue (2016-2021) 2.5.2 Global Top Infection Prevention Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Infection Prevention Sales by Manufacturers 3.1.1 Global Top Infection Prevention Manufacturers by Sales (2016-2021) 3.1.2 Global Top Infection Prevention Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Infection Prevention Sales in 2020 3.2 Global Infection Prevention Revenue by Manufacturers 3.2.1 Global Top Infection Prevention Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Infection Prevention Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Infection Prevention Revenue in 2020 3.3 Global Infection Prevention Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Infection Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Infection Prevention Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Infection Prevention Sales by Type 4.1.1 Global Infection Prevention Historical Sales by Type (2016-2021) 4.1.2 Global Infection Prevention Forecasted Sales by Type (2022-2027) 4.1.3 Global Infection Prevention Sales Market Share by Type (2016-2027) 4.2 Global Infection Prevention Revenue by Type 4.2.1 Global Infection Prevention Historical Revenue by Type (2016-2021) 4.2.2 Global Infection Prevention Forecasted Revenue by Type (2022-2027) 4.2.3 Global Infection Prevention Revenue Market Share by Type (2016-2027) 4.3 Global Infection Prevention Price by Type 4.3.1 Global Infection Prevention Price by Type (2016-2021) 4.3.2 Global Infection Prevention Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Infection Prevention Sales by Application 5.1.1 Global Infection Prevention Historical Sales by Application (2016-2021) 5.1.2 Global Infection Prevention Forecasted Sales by Application (2022-2027) 5.1.3 Global Infection Prevention Sales Market Share by Application (2016-2027) 5.2 Global Infection Prevention Revenue by Application 5.2.1 Global Infection Prevention Historical Revenue by Application (2016-2021) 5.2.2 Global Infection Prevention Forecasted Revenue by Application (2022-2027) 5.2.3 Global Infection Prevention Revenue Market Share by Application (2016-2027) 5.3 Global Infection Prevention Price by Application 5.3.1 Global Infection Prevention Price by Application (2016-2021) 5.3.2 Global Infection Prevention Price Forecast by Application (2022-2027) 6 North America 6.1 North America Infection Prevention Market Size by Type 6.1.1 North America Infection Prevention Sales by Type (2016-2027) 6.1.2 North America Infection Prevention Revenue by Type (2016-2027) 6.2 North America Infection Prevention Market Size by Application 6.2.1 North America Infection Prevention Sales by Application (2016-2027) 6.2.2 North America Infection Prevention Revenue by Application (2016-2027) 6.3 North America Infection Prevention Market Size by Country 6.3.1 North America Infection Prevention Sales by Country (2016-2027) 6.3.2 North America Infection Prevention Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Infection Prevention Market Size by Type 7.1.1 Europe Infection Prevention Sales by Type (2017-2027) 7.1.2 Europe Infection Prevention Revenue by Type (2017-2027) 7.2 Europe Infection Prevention Market Size by Application 7.2.1 Europe Infection Prevention Sales by Application (2017-2027) 7.2.2 Europe Infection Prevention Revenue by Application (2017-2027) 7.3 Europe Infection Prevention Market Size by Country 7.3.1 Europe Infection Prevention Sales by Country (2017-2027) 7.3.2 Europe Infection Prevention Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Infection Prevention Market Size by Type 8.1.1 Asia Pacific Infection Prevention Sales by Type (2018-2027) 8.1.2 Asia Pacific Infection Prevention Revenue by Type (2018-2027) 8.2 Asia Pacific Infection Prevention Market Size by Application 8.2.1 Asia Pacific Infection Prevention Sales by Application (2018-2027) 8.2.2 Asia Pacific Infection Prevention Revenue by Application (2018-2027) 8.3 Asia Pacific Infection Prevention Market Size by Region 8.3.1 Asia Pacific Infection Prevention Sales by Region (2018-2027) 8.3.2 Asia Pacific Infection Prevention Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Infection Prevention Market Size by Type 9.1.1 Latin America Infection Prevention Sales by Type (2019-2027) 9.1.2 Latin America Infection Prevention Revenue by Type (2019-2027) 9.2 Latin America Infection Prevention Market Size by Application 9.2.1 Latin America Infection Prevention Sales by Application (2019-2027) 9.2.2 Latin America Infection Prevention Revenue by Application (2019-2027) 9.3 Latin America Infection Prevention Market Size by Country 9.3.1 Latin America Infection Prevention Sales by Country (2019-2027) 9.3.2 Latin America Infection Prevention Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Infection Prevention Market Size by Type 6.1.1 Middle East and Africa Infection Prevention Sales by Type (2016-2027) 6.1.2 Middle East and Africa Infection Prevention Revenue by Type (2016-2027) 6.2 Middle East and Africa Infection Prevention Market Size by Application 6.2.1 Middle East and Africa Infection Prevention Sales by Application (2016-2027) 6.2.2 Middle East and Africa Infection Prevention Revenue by Application (2016-2027) 6.3 Middle East and Africa Infection Prevention Market Size by Country 6.3.1 Middle East and Africa Infection Prevention Sales by Country (2016-2027) 6.3.2 Middle East and Africa Infection Prevention Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 3M 11.1.1 3M Corporation Information 11.1.2 3M Overview 11.1.3 3M Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 3M Infection Prevention Product Description 11.1.5 3M Related Developments 11.2 BD 11.2.1 BD Corporation Information 11.2.2 BD Overview 11.2.3 BD Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 BD Infection Prevention Product Description 11.2.5 BD Related Developments 11.3 Belimed 11.3.1 Belimed Corporation Information 11.3.2 Belimed Overview 11.3.3 Belimed Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Belimed Infection Prevention Product Description 11.3.5 Belimed Related Developments 11.4 Biomerieux 11.4.1 Biomerieux Corporation Information 11.4.2 Biomerieux Overview 11.4.3 Biomerieux Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Biomerieux Infection Prevention Product Description 11.4.5 Biomerieux Related Developments 11.5 Getinge 11.5.1 Getinge Corporation Information 11.5.2 Getinge Overview 11.5.3 Getinge Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Getinge Infection Prevention Product Description 11.5.5 Getinge Related Developments 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Corporation Information 11.6.2 Johnson & Johnson Overview 11.6.3 Johnson & Johnson Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Johnson & Johnson Infection Prevention Product Description 11.6.5 Johnson & Johnson Related Developments 11.7 Kimberly-Clark 11.7.1 Kimberly-Clark Corporation Information 11.7.2 Kimberly-Clark Overview 11.7.3 Kimberly-Clark Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Kimberly-Clark Infection Prevention Product Description 11.7.5 Kimberly-Clark Related Developments 11.8 Sotera Health 11.8.1 Sotera Health Corporation Information 11.8.2 Sotera Health Overview 11.8.3 Sotera Health Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Sotera Health Infection Prevention Product Description 11.8.5 Sotera Health Related Developments 11.9 Ansell Limited 11.9.1 Ansell Limited Corporation Information 11.9.2 Ansell Limited Overview 11.9.3 Ansell Limited Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Ansell Limited Infection Prevention Product Description 11.9.5 Ansell Limited Related Developments 11.10 Steris 11.10.1 Steris Corporation Information 11.10.2 Steris Overview 11.10.3 Steris Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Steris Infection Prevention Product Description 11.10.5 Steris Related Developments 11.1 3M 11.1.1 3M Corporation Information 11.1.2 3M Overview 11.1.3 3M Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 3M Infection Prevention Product Description 11.1.5 3M Related Developments 11.12 Pacon Manufacturing 11.12.1 Pacon Manufacturing Corporation Information 11.12.2 Pacon Manufacturing Overview 11.12.3 Pacon Manufacturing Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Pacon Manufacturing Product Description 11.12.5 Pacon Manufacturing Related Developments 11.13 American Polyfilm 11.13.1 American Polyfilm Corporation Information 11.13.2 American Polyfilm Overview 11.13.3 American Polyfilm Infection Prevention Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 American Polyfilm Product Description 11.13.5 American Polyfilm Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Infection Prevention Value Chain Analysis 12.2 Infection Prevention Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Infection Prevention Production Mode & Process 12.4 Infection Prevention Sales and Marketing 12.4.1 Infection Prevention Sales Channels 12.4.2 Infection Prevention Distributors 12.5 Infection Prevention Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Infection Prevention Industry Trends 13.2 Infection Prevention Market Drivers 13.3 Infection Prevention Market Challenges 13.4 Infection Prevention Market Restraints 14 Key Findings in The Global Infection Prevention Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Infection Prevention Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Disinfectors Table 3. Major Manufacturers of Sterilization Equipment Table 4. Major Manufacturers of Others Table 5. Global Infection Prevention Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Infection Prevention Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Infection Prevention Sales by Region (2016-2021) & (K Units) Table 8. Global Infection Prevention Sales Market Share by Region (2016-2021) Table 9. Global Infection Prevention Sales by Region (2016-2021) & (K Units) Table 10. Global Infection Prevention Sales Market Share by Region (2022-2027) Table 11. Global Infection Prevention Revenue by Region (2016-2021) & (US$ Million) Table 12. Global Infection Prevention Revenue Market Share by Region (2016-2021) Table 13. Global Infection Prevention Revenue by Region (2022-2027) & (US$ Million) Table 14. Global Infection Prevention Revenue Market Share by Region (2022-2027) Table 15. Global Infection Prevention Sales by Manufacturers (2016-2021) & (K Units) Table 16. Global Infection Prevention Sales Share by Manufacturers (2016-2021) Table 17. Global Infection Prevention Revenue by Manufacturers (2016-2021) & (US$ Million) Table 18. Global Infection Prevention Revenue Share by Manufacturers (2016-2021) Table 19. Infection Prevention Price by Manufacturers 2016-2021 (USD/Unit) Table 20. Global Infection Prevention Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Infection Prevention by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection Prevention as of 2020) Table 22. Infection Prevention Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Infection Prevention Product Offered Table 24. Date of Manufacturers Enter into Infection Prevention Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Infection Prevention Sales by Type (2016-2021) & (K Units) Table 27. Global Infection Prevention Sales by Type (2022-2027) & (K Units) Table 28. Global Infection Prevention Sales Share by Type (2016-2021) Table 29. Global Infection Prevention Sales Share by Type (2022-2027) Table 30. Global Infection Prevention Revenue by Type (2016-2021) & (US$ Million) Table 31. Global Infection Prevention Revenue by Type (2022-2027) & (US$ Million) Table 32. Global Infection Prevention Revenue Share by Type (2016-2021) Table 33. Global Infection Prevention Revenue Share by Type (2022-2027) Table 34. Infection Prevention Price by Type (2016-2021) & (USD/Unit) Table 35. Global Infection Prevention Price Forecast by Type (2022-2027) & (USD/Unit) Table 36. Global Infection Prevention Sales by Application (2016-2021) & (K Units) Table 37. Global Infection Prevention Sales by Application (2022-2027) & (K Units) Table 38. Global Infection Prevention Sales Share by Application (2016-2021) Table 39. Global Infection Prevention Sales Share by Application (2022-2027) Table 40. Global Infection Prevention Revenue by Application (2016-2021) & (US$ Million) Table 41. Global Infection Prevention Revenue by Application (2022-2027) & (US$ Million) Table 42. Global Infection Prevention Revenue Share by Application (2016-2021) Table 43. Global Infection Prevention Revenue Share by Application (2022-2027) Table 44. Infection Prevention Price by Application (2016-2021) & (USD/Unit) Table 45. Global Infection Prevention Price Forecast by Application (2022-2027) & (USD/Unit) Table 46. North America Infection Prevention Sales by Type (2016-2021) & (K Units) Table 47. North America Infection Prevention Sales by Type (2022-2027) & (K Units) Table 48. North America Infection Prevention Revenue by Type (2016-2021) & (US$ Million) Table 49. North America Infection Prevention Revenue by Type (2022-2027) & (US$ Million) Table 50. North America Infection Prevention Sales by Application (2016-2021) & (K Units) Table 51. North America Infection Prevention Sales by Application (2022-2027) & (K Units) Table 52. North America Infection Prevention Revenue by Application (2016-2021) & (US$ Million) Table 53. North America Infection Prevention Revenue by Application (2022-2027) & (US$ Million) Table 54. North America Infection Prevention Sales by Country (2016-2021) & (K Units) Table 55. North America Infection Prevention Sales by Country (2022-2027) & (K Units) Table 56. North America Infection Prevention Revenue by Country (2016-2021) & (US$ Million) Table 57. North America Infection Prevention Revenue by Country (2022-2027) & (US$ Million) Table 58. Europe Infection Prevention Sales by Type (2016-2021) & (K Units) Table 59. Europe Infection Prevention Sales by Type (2022-2027) & (K Units) Table 60. Europe Infection Prevention Revenue by Type (2016-2021) & (US$ Million) Table 61. Europe Infection Prevention Revenue by Type (2022-2027) & (US$ Million) Table 62. Europe Infection Prevention Sales by Application (2016-2021) & (K Units) Table 63. Europe Infection Prevention Sales by Application (2022-2027) & (K Units) Table 64. Europe Infection Prevention Revenue by Application (2016-2021) & (US$ Million) Table 65. Europe Infection Prevention Revenue by Application (2022-2027) & (US$ Million) Table 66. Europe Infection Prevention Sales by Country (2016-2021) & (K Units) Table 67. Europe Infection Prevention Sales by Country (2022-2027) & (K Units) Table 68. Europe Infection Prevention Revenue by Country (2016-2021) & (US$ Million) Table 69. Europe Infection Prevention Revenue by Country (2022-2027) & (US$ Million) Table 70. Asia Pacific Infection Prevention Sales by Type (2016-2021) & (K Units) Table 71. Asia Pacific Infection Prevention Sales by Type (2022-2027) & (K Units) Table 72. Asia Pacific Infection Prevention Revenue by Type (2016-2021) & (US$ Million) Table 73. Asia Pacific Infection Prevention Revenue by Type (2022-2027) & (US$ Million) Table 74. Asia Pacific Infection Prevention Sales by Application (2016-2021) & (K Units) Table 75. Asia Pacific Infection Prevention Sales by Application (2022-2027) & (K Units) Table 76. Asia Pacific Infection Prevention Revenue by Application (2016-2021) & (US$ Million) Table 77. Asia Pacific Infection Prevention Revenue by Application (2022-2027) & (US$ Million) Table 78. Asia Pacific Infection Prevention Sales by Region (2016-2021) & (K Units) Table 79. Asia Pacific Infection Prevention Sales by Region (2022-2027) & (K Units) Table 80. Asia Pacific Infection Prevention Revenue by Region (2016-2021) & (US$ Million) Table 81. Asia Pacific Infection Prevention Revenue by Region (2022-2027) & (US$ Million) Table 82. Latin America Infection Prevention Sales by Type (2016-2021) & (K Units) Table 83. Latin America Infection Prevention Sales by Type (2022-2027) & (K Units) Table 84. Latin America Infection Prevention Revenue by Type (2016-2021) & (US$ Million) Table 85. Latin America Infection Prevention Revenue by Type (2022-2027) & (US$ Million) Table 86. Latin America Infection Prevention Sales by Application (2016-2021) & (K Units) Table 87. Latin America Infection Prevention Sales by Application (2022-2027) & (K Units) Table 88. Latin America Infection Prevention Revenue by Application (2016-2021) & (US$ Million) Table 89. Latin America Infection Prevention Revenue by Application (2022-2027) & (US$ Million) Table 90. Latin America Infection Prevention Sales by Country (2016-2021) & (K Units) Table 91. Latin America Infection Prevention Sales by Country (2022-2027) & (K Units) Table 92. Latin America Infection Prevention Revenue by Country (2016-2021) & (US$ Million) Table 93. Latin America Infection Prevention Revenue by Country (2022-2027) & (US$ Million) Table 94. Middle East and Africa Infection Prevention Sales by Type (2016-2021) & (K Units) Table 95. Middle East and Africa Infection Prevention Sales by Type (2022-2027) & (K Units) Table 96. Middle East and Africa Infection Prevention Revenue by Type (2016-2021) & (US$ Million) Table 97. Middle East and Africa Infection Prevention Revenue by Type (2022-2027) & (US$ Million) Table 98. Middle East and Africa Infection Prevention Sales by Application (2016-2021) & (K Units) Table 99. Middle East and Africa Infection Prevention Sales by Application (2022-2027) & (K Units) Table 100. Middle East and Africa Infection Prevention Revenue by Application (2016-2021) & (US$ Million) Table 101. Middle East and Africa Infection Prevention Revenue by Application (2022-2027) & (US$ Million) Table 102. Middle East and Africa Infection Prevention Sales by Country (2016-2021) & (K Units) Table 103. Middle East and Africa Infection Prevention Sales by Country (2022-2027) & (K Units) Table 104. Middle East and Africa Infection Prevention Revenue by Country (2016-2021) & (US$ Million) Table 105. Middle East and Africa Infection Prevention Revenue by Country (2022-2027) & (US$ Million) Table 106. 3M Corporation Information Table 107. 3M Description and Major Businesses Table 108. 3M Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 109. 3M Infection Prevention Product Table 110. 3M Recent Developments Table 111. BD Corporation Information Table 112. BD Description and Major Businesses Table 113. BD Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 114. BD Infection Prevention Product Table 115. BD Recent Developments Table 116. Belimed Corporation Information Table 117. Belimed Description and Major Businesses Table 118. Belimed Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 119. Belimed Infection Prevention Product Table 120. Belimed Recent Developments Table 121. Biomerieux Corporation Information Table 122. Biomerieux Description and Major Businesses Table 123. Biomerieux Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 124. Biomerieux Infection Prevention Product Table 125. Biomerieux Recent Developments Table 126. Getinge Corporation Information Table 127. Getinge Description and Major Businesses Table 128. Getinge Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 129. Getinge Infection Prevention Product Table 130. Getinge Recent Developments Table 131. Johnson & Johnson Corporation Information Table 132. Johnson & Johnson Description and Major Businesses Table 133. Johnson & Johnson Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 134. Johnson & Johnson Infection Prevention Product Table 135. Johnson & Johnson Recent Developments Table 136. Kimberly-Clark Corporation Information Table 137. Kimberly-Clark Description and Major Businesses Table 138. Kimberly-Clark Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 139. Kimberly-Clark Infection Prevention Product Table 140. Kimberly-Clark Recent Developments Table 141. Sotera Health Corporation Information Table 142. Sotera Health Description and Major Businesses Table 143. Sotera Health Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 144. Sotera Health Infection Prevention Product Table 145. Sotera Health Recent Developments Table 146. Ansell Limited Corporation Information Table 147. Ansell Limited Description and Major Businesses Table 148. Ansell Limited Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 149. Ansell Limited Infection Prevention Product Table 150. Ansell Limited Recent Developments Table 151. Steris Corporation Information Table 152. Steris Description and Major Businesses Table 153. Steris Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 154. Steris Infection Prevention Product Table 155. Steris Recent Developments Table 156. Lac-Mac Corporation Information Table 157. Lac-Mac Description and Major Businesses Table 158. Lac-Mac Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 159. Lac-Mac Infection Prevention Product Table 160. Lac-Mac Recent Developments Table 161. Pacon Manufacturing Corporation Information Table 162. Pacon Manufacturing Description and Major Businesses Table 163. Pacon Manufacturing Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 164. Pacon Manufacturing Infection Prevention Product Table 165. Pacon Manufacturing Recent Developments Table 166. American Polyfilm Corporation Information Table 167. American Polyfilm Description and Major Businesses Table 168. American Polyfilm Infection Prevention Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 169. American Polyfilm Infection Prevention Product Table 170. American Polyfilm Recent Developments Table 171. Key Raw Materials Lists Table 172. Raw Materials Key Suppliers Lists Table 173. Infection Prevention Distributors List Table 174. Infection Prevention Customers List Table 175. Infection Prevention Market Trends Table 176. Infection Prevention Market Drivers Table 177. Infection Prevention Market Challenges Table 178. Infection Prevention Market Restraints Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Infection Prevention Product Picture Figure 2. Global Infection Prevention Market Share by Type in 2020 & 2027 Figure 3. Disinfectors Product Picture Figure 4. Sterilization Equipment Product Picture Figure 5. Others Product Picture Figure 6. Global Infection Prevention Sales Market Share by Application in 2020 & 2027 Figure 7. Hospitals Figure 8. Clinics Figure 9. Others Figure 10. Infection Prevention Report Years Considered Figure 11. Global Infection Prevention Sales 2016-2027 (K Units) Figure 12. Global Infection Prevention Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Infection Prevention Revenue 2016-2027 (US$ Million) Figure 14. Global Infection Prevention Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 15. Global Infection Prevention Sales Market Share by Region (2016-2021) Figure 16. Global Infection Prevention Sales Market Share by Region (2022-2027) Figure 17. North America Infection Prevention Sales YoY (2016-2027) & (K Units) Figure 18. North America Infection Prevention Revenue YoY (2016-2027) & (US$ Million) Figure 19. Europe Infection Prevention Sales YoY (2016-2027) & (K Units) Figure 20. Europe Infection Prevention Revenue YoY (2016-2027) & (US$ Million) Figure 21. Asia-Pacific Infection Prevention Sales YoY (2016-2027) & (K Units) Figure 22. Asia-Pacific Infection Prevention Revenue YoY (2016-2027) & (US$ Million) Figure 23. Latin America Infection Prevention Sales YoY (2016-2027) & (K Units) Figure 24. Latin America Infection Prevention Revenue YoY (2016-2027) & (US$ Million) Figure 25. Middle East & Africa Infection Prevention Sales YoY (2016-2027) & (K Units) Figure 26. Middle East & Africa Infection Prevention Revenue YoY (2016-2027) & (US$ Million) Figure 27. The Top 10 and Top 5 Players Market Share by Infection Prevention Sales in 2020 Figure 28. The Top 10 and Top 5 Players Market Share by Infection Prevention Revenue in 2020 Figure 29. Infection Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 30. Global Infection Prevention Sales Market Share by Type (2016-2027) Figure 31. Global Infection Prevention Revenue Market Share by Type (2016-2027) Figure 32. Global Infection Prevention Sales Market Share by Application (2016-2027) Figure 33. Global Infection Prevention Revenue Market Share by Application (2016-2027) Figure 34. North America Infection Prevention Sales Market Share by Type (2016-2027) Figure 35. North America Infection Prevention Revenue Market Share by Type (2016-2027) Figure 36. North America Infection Prevention Sales Market Share by Application (2016-2027) Figure 37. North America Infection Prevention Revenue Market Share by Application (2016-2027) Figure 38. North America Infection Prevention Sales Share by Country (2016-2027) Figure 39. North America Infection Prevention Revenue Share by Country (2016-2027) Figure 40. U.S. Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 41. Canada Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 42. Europe Infection Prevention Sales Market Share by Type (2016-2027) Figure 43. Europe Infection Prevention Revenue Market Share by Type (2016-2027) Figure 44. Europe Infection Prevention Sales Market Share by Application (2016-2027) Figure 45. Europe Infection Prevention Revenue Market Share by Application (2016-2027) Figure 46. Europe Infection Prevention Sales Share by Country (2016-2027) Figure 47. Europe Infection Prevention Revenue Share by Country (2016-2027) Figure 48. Germany Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 49. France Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 50. U.K. Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 51. Italy Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 52. Russia Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 53. Asia Pacific Infection Prevention Sales Market Share by Type (2016-2027) Figure 54. Asia Pacific Infection Prevention Revenue Market Share by Type (2016-2027) Figure 55. Asia Pacific Infection Prevention Sales Market Share by Application (2016-2027) Figure 56. Asia Pacific Infection Prevention Revenue Market Share by Application (2016-2027) Figure 57. Asia Pacific Infection Prevention Sales Share by Region (2016-2027) Figure 58. Asia Pacific Infection Prevention Revenue Share by Region (2016-2027) Figure 59. China Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 60. Japan Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 61. South Korea Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 62. India Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 63. Australia Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 64. Taiwan Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 65. Indonesia Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 66. Thailand Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 67. Malaysia Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 68. Philippines Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 69. Latin America Infection Prevention Sales Market Share by Type (2016-2027) Figure 70. Latin America Infection Prevention Revenue Market Share by Type (2016-2027) Figure 71. Latin America Infection Prevention Sales Market Share by Application (2016-2027) Figure 72. Latin America Infection Prevention Revenue Market Share by Application (2016-2027) Figure 73. Latin America Infection Prevention Sales Share by Country (2016-2027) Figure 74. Latin America Infection Prevention Revenue Share by Country (2016-2027) Figure 75. Mexico Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 76. Brazil Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 77. Argentina Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 78. Middle East and Africa Infection Prevention Sales Market Share by Type (2016-2027) Figure 79. Middle East and Africa Infection Prevention Revenue Market Share by Type (2016-2027) Figure 80. Middle East and Africa Infection Prevention Sales Market Share by Application (2016-2027) Figure 81. Middle East and Africa Infection Prevention Revenue Market Share by Application (2016-2027) Figure 82. Middle East and Africa Infection Prevention Sales Share by Country (2016-2027) Figure 83. Middle East and Africa Infection Prevention Revenue Share by Country (2016-2027) Figure 84. Turkey Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 85. Saudi Arabia Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 86. U.A.E Infection Prevention Revenue (2016-2027) & (US$ Million) Figure 87. Infection Prevention Value Chain Figure 88. Infection Prevention Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

3M BD Belimed Biomerieux Getinge Johnson & Johnson Kimberly-Clark Sotera Health Ansell Limited Steris Lac-Mac Pacon Manufacturing American Polyfilm